Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of The Bancorp, Inc. during the specified class period of the upcoming lead plaintiff deadline on May 16, 2025, and highlights the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - Investors who purchased Bancorp securities between January 25, 2024, and March 4, 2025, may be eligible to join a class action lawsuit [1]. - A class action lawsuit has already been filed, and interested parties must act by the lead plaintiff deadline [2]. - The lawsuit alleges that Bancorp made false and misleading statements regarding its financial health and risk management practices, particularly concerning its real estate bridge loan portfolio [4]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [3]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been recognized for its success in this area [3]. - Investors are encouraged to be cautious in choosing legal representation, as many firms may not have the necessary experience or resources [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Sana Biotechnology, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on May 20, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Sana securities between March 17, 2023, and November 4, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by May 20, 2025 [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Allegations Against Sana Biotechnology - The lawsuit alleges that during the Class Period, Sana made false or misleading statements regarding its financial stability and the potential of its product candidates [4]. - Specific claims include that Sana was at significant risk of insufficient funds, that certain product candidates were less promising than represented, and that the company was likely to decrease funding for some projects and reduce its workforce [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Perpetua Resources Corp. during the specified Class Period of the upcoming lead plaintiff deadline on May 20, 2025 [1]. Group 1: Class Action Details - Investors who purchased Perpetua securities between April 17, 2024, and February 13, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lead plaintiff must file a motion with the Court by May 20, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting their own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Rosen Law Firm has been recognized as a leader in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4]. Group 3: Case Background - The lawsuit alleges that during the Class Period, Perpetua's Defendants provided misleading information regarding the expected initial capital expenditure for the Stibnite Gold Project, downplaying the impact of inflation and other cost factors [5]. - The misleading statements led investors to purchase Perpetua's securities at artificially inflated prices, resulting in damages when the true costs were revealed [5].

Core Viewpoint - Rosen Law Firm is reminding purchasers of Ibotta, Inc. securities about a class action lawsuit related to the company's April 2024 IPO, with a lead plaintiff deadline set for June 16, 2025 [1]. Group 1: Class Action Details - Investors who purchased Ibotta securities may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6]. - The lawsuit claims that Ibotta's Registration Statement contained false or misleading statements regarding its contract with Kroger, which was at-will, posing a risk that Kroger could cancel the contract without notice [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Perpetua Resources Corp. during the specified Class Period of the upcoming lead plaintiff deadline on May 20, 2025 [1]. Group 1: Class Action Details - Investors who purchased Perpetua securities between April 17, 2024, and February 13, 2025, may be entitled to compensation through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the law firm [3][6]. - The lawsuit claims that Perpetua's management provided misleading information regarding the initial capital expenditure for the Stibnite Gold Project, leading to inflated security prices [5]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Treace Medical Concepts, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on June 10, 2025 [1]. Group 1: Class Action Details - Investors who purchased Treace Medical securities between May 8, 2023, and May 7, 2024, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting the Rosen Law Firm [3][6]. - The lawsuit claims that Treace Medical made false or misleading statements regarding its business operations and the impact of competition on its primary product, the Lapiplasty 3D Bunion Correction System [5]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been recognized for its performance in securities class action settlements [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Ultra Clean Holdings, Inc. during the specified Class Period of the upcoming lead plaintiff deadline on May 23, 2025 [1]. Group 1: Class Action Details - Investors who purchased Ultra Clean securities between May 6, 2024, and February 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Ultra Clean misrepresented the demand for its products in the Chinese market, leading to investor damages when the true situation was revealed [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of Zenas BioPharma, Inc. securities related to its September 2024 IPO, alleging misleading statements in the Registration Statement [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Zenas BioPharma overstated its ability to fund operations with existing cash and expected IPO proceeds, leading to materially false public statements [5]. - Investors who purchased Zenas BioPharma securities may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by June 16, 2025, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased enCore Energy Corp. securities between March 28, 2024, and March 2, 2025, of the May 13, 2025, deadline to become lead plaintiffs in a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought enCore securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court by May 13, 2025, to serve as lead plaintiff [2]. - The lawsuit alleges that enCore made false or misleading statements and failed to disclose significant issues regarding its internal controls and financial reporting, leading to increased net losses [4]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [3]. - The firm achieved the largest securities class action settlement against a Chinese company at the time and has been consistently ranked among the top firms for securities class action settlements since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [3].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Maravai Lifesciences Holdings, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on May 5, 2025 [1]. Group 1: Class Action Details - Investors who purchased Maravai securities between August 7, 2024, and February 24, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6]. - The lawsuit claims that Maravai made false or misleading statements regarding its financial reporting and internal controls, leading to inaccurate revenue recognition and overstated goodwill [5]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4].